From eNewsletter 1/5/2022
DID YOU KNOW that the cells in your body are constantly renewing themselves, with older cells aging and dying as new ones are being born? But sometimes that process goes awry. Occasionally damaged cells linger. Called senescent cells, they hang around, acting as a bad influence on other cells nearby. Their bad influence changes how the neighboring cells handle sugars or proteins , thus causing metabolic problems, such as type 2 diabetes. Clearing away those senescent cells seems to stop diabetic behavior, according to a study in Cell Metabolism. And of the two substances that protected against the harmful effects of the fat tissue, one of them was quercetin!
Food Intolerance Test Blood Draw Update Options to set up a Biotrition food intolerance test blood draw. By appointment only:
One Saturday per month at Biotrition in Glenview - 1/22/22 and 2/12/2
Tue, Wed, TH 9AM-3PM at NICL Labs in Northbrook
Text, email, or call us to set up your appointment.
Text Us To better serve your needs, we now have the ability to accept text messages. Simply type in (847) 498-3422 and text away!
UPDATE - COVID-19 Vaccine Information We updated this document Monday, January 3rd.
Virus Prevention And Treatment Vaccines will minimize COVID-19 related mortality and hospitalizations, but SARS-CoV-2 is not going away, as evidenced by its ever-mutating variants. Moreover, SARS-CoV-2 is not the only virus we fight. There are influenza (flu), norovirus (stomach flu), adenovirus (common cold), and four other coronaviruses (common cold), among others.We highly recommend continuing your immune support. For more information, refer to our Prevent and Fight Viruses 2.0 Protocol.
COVID-19 Condition Monograph For those interested in conventional and integrative treatments for COVID-19 with over 250 references, this is our COVID-19 Condition Monograph.
UPDATE - Post-COVID Syndrome 2.0 (November 2021) The official diagnosis for post-COVID syndrome (PCS) are symptoms that last for 12 weeks or more. If you, a family member, friend, coworker, or neighbor is suffering from PCS, diligently following our Post-COVID Syndrome 2.0 Action Plan for purchase, or free to paid members here, can bring measurable improvement.
Have a happy, healthy day! Steve and Bonnie Minsky
In Today's Issue...
Well Connect Feature: Menopause Update*
January 20% OFF Sale Items
Chiro Corner NEW!
Well Connect Member Benefits
*Paid Member Access Only
Steve: Over the last week, there has been a bevy of research on the Omicron variant. The most important early discovery is that Omicron DOES NOT escape T cell immunity. T cells come along after two or three days of symptomatic infection to knock it out. While prior variants were able to bypass T cell immunity and wreak havoc around the rest of the body, for those who have already had COVID-19 infection or COVID-19 vaccination, the early returns indicate T cells won't let Omicron escape. This may explain why experts are finding Omicron is less severe for most. *If you want to see at a microscopic level what it looks like when our immune system attacks SARS-CoV-2, look at the first image of this newsletter. The next 6-8 weeks are going to be a rough ride because of the sheer numbers who are going to be infected with Omicron. We have already heard from a slew of clients who have gotten Omicron who were either asymptomatic or sick for a day or two with cold/flu-like symptoms. Stay the course with your diet, lifestyle, and supplemental protocols. We will come out on the other side better as a society because SARS-CoV-2 and humans will have finally learned to how to coexist without indiscriminate severe illness or death. What ER Doctors Are Seeing and More The general trend is if you have been vaccinated or had a previous COVID-19 infection, you really just at worst end up with bad cold symptoms from the Omicron variant. There are exceptions if you have a very weakened immune system. Cases continue to skyrocket, but hospitalizations and deaths remain much lower by comparison, another sign that Omicron is less deadly than previous strains, White House officials said last week. "The rapid increase of cases we're seeing across the country is, in large part, a reflection of the exceptionally transmissible Omicron variant," CDC Director Rochelle Walensky said. "While our cases have substantially increased from last week, hospitalizations and deaths remain comparatively low right now. Early indications we've seen from other countries like South Africa and the United Kingdom have shown milder disease from Omicron," she continued. Ditch Cloth Masks? Amid the rapidly spreading Omicron variant, experts stress that we should swap cloth masks for N95 respirators or 3-ply surgical masks. N95 respirators are tightly fitting masks that cover your mouth and nose and help prevent contact with droplets and tiny particles in the air from people talking, coughing, sneezing, and spreading in other ways. Usually worn by health care workers and first responders, these masks can filter up to 95% of air droplets and particles. Are Rapid COVID Tests Less Sensitive? Early data suggest that COVID-19 antigen tests "do detect the omicron variant but may have reduced sensitivity," the FDA said in a statement posted last week. The FDA is working with the National Institutes of Health's Rapid Acceleration of Diagnostics initiative to assess the performance of antigen tests with patient samples that have the Omicron variant. This is only early data so be skeptical of this for now. Omicron Leads to Huge Increase in Asymptomatic Cases Findings from a study in Medrxiv strongly suggest that Omicron has a much higher rate of asymptomatic carriage than previous variants. This is positive sign because it shows the variant is less severe and it will spread to many more people around the world with less deleterious effects. Two Doses or Three Vaccine Doses? Early data suggest the third dose of vaccination, also referred to as a booster, only offers protection from infection for a very short period of time, but continues to prevent severe illness and disease. Researchers publishing in Medrxiv and New England Journal of Medicine confirmed that two doses of the vaccine also robustly protects from severe illness and death from the Omicron variant. Ominous Data Regarding COVID-19 Pills The FDA has issued emergency use authorization to a second oral COVID-19 treatment. Called molnupiravir, the new drug from Merck is not as effective as Pfizer’s recently approved COVID antiviral pill, and many experts suggest the FDA should never have authorized it in the first place as it has the potential to generate new SARS-CoV-2 variants. Unfortunately, the Pfizer pill has its own issues. The FDA authorized Pfizer’s Paxlovid for mild to moderate COVID in people as young as 12 who have underlying conditions that raise the risk of hospitalization and death from the coronavirus, such as heart disease or diabetes. However, one of the two drugs in the antiviral cocktail could cause severe or life-threatening interactions with widely used medications, including statins, blood thinners and some antidepressants. And the FDA does not recommend Paxlovid for people with severe kidney or liver disease.